# Eisai, Inc., Nutley, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/eisai-inc/081df088-ce18-4702-a2b3-cb4e48ebe3e4

> Inspection records and compliance data for Eisai, Inc. in Nutley, New Jersey. 7 FDA inspections on record, 1 Form 483, last inspected May 02, 2025.

---

## Details

- Name: Eisai, Inc.
- FEI Number: 3009413786
- Address Line 1: 200 Metro Blvd
- City: Nutley
- State: New Jersey
- Zip Code: 07110
- Country Name: United States
- Address: 200 Metro Blvd, Nutley, New Jersey 07110, United States
- Country: United States

## Related Documents

- FDA Inspection 1271039 - Eisai, Inc. - 2025-05-02 — source: FDA, date: May 2, 2025
- FDA Inspection 1271039 - Eisai, Inc. - 2025-05-02 — classification: No Action Indicated (NAI), source: FDA, date: May 2, 2025
- FDA Inspection 1198163 - Eisai, Inc. - 2023-02-09 — classification: No Action Indicated (NAI), source: FDA, date: February 9, 2023
- [483 - Eisai, Inc. - 2018-02-16](https://www.keypedia.com/records/483/eisai-inc/589d69b0-e1da-4820-8438-7f8b469d31af) — source: FDA, date: February 16, 2018
- FDA Inspection 1041308 - Eisai, Inc. - 2018-02-16 — classification: No Action Indicated (NAI), source: FDA, date: February 16, 2018
- [FDA Inspection 1041308 - Eisai, Inc. - 2018-02-16](https://www.keypedia.com/records/fda_inspections/eisai-inc/a2dda4fb-11b0-48c4-8bae-404e6e8e2162) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 16, 2018
- [FDA Inspection 965277 - Eisai, Inc. - 2015-12-09](https://www.keypedia.com/records/fda_inspections/eisai-inc/91c61b0b-ff73-4d59-8170-c48c8c02431d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 9, 2015
- FDA Inspection 922940 - Eisai, Inc. - 2015-04-20 — classification: No Action Indicated (NAI), source: FDA, date: April 20, 2015
- [FDA Inspection 813538 - Eisai, Inc. - 2013-01-17](https://www.keypedia.com/records/fda_inspections/eisai-inc/67abb28d-22d3-4612-9cee-079c7e62a668) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 17, 2013
- FDA Inspection 683663 - Eisai, Inc. - 2010-09-27 — classification: No Action Indicated (NAI), source: FDA, date: September 27, 2010

## Related Companies

- [Teva Pharmaceuticals USA, Inc](https://www.keypedia.com/companies/teva-pharmaceuticals-usa-inc/16ce5163-b7e9-4f34-adce-197945dc8b53)
- [Cody Laboratories, Inc.](https://www.keypedia.com/companies/cody-laboratories-inc/ff687af7-da97-441d-b0cd-7f20af5e87a9)
- [Ei LLC](https://www.keypedia.com/companies/ei-llc/88b53134-ac99-4eb2-b709-2a80a826ad7d)
- [Taro Pharmaceuticals U.S.A., Inc.](https://www.keypedia.com/companies/taro-pharmaceuticals-usa-inc/05da273e-af73-473f-a144-af7c4e2972c9)
- [Actavis Italy Spa A Socio Unico](https://www.keypedia.com/companies/actavis-italy-spa-a-socio-unico/7c4ac702-d647-4c5d-a853-472db165127e)
- [Lambda Therapeutic Research Ltd.](https://www.keypedia.com/companies/lambda-therapeutic-research-ltd/e4515c16-4ff4-451a-9d2f-b4b1668eb47c)
- [Sagent Pharmaceuticals](https://www.keypedia.com/companies/sagent-pharmaceuticals/9b7830c1-51dd-4d82-8287-b320eff537fd)
- [David L. Wirta, M.D.](https://www.keypedia.com/companies/david-l-wirta-md/f239b2b9-d44b-4aa0-b2e3-3506e3831bae)
- [AltaSciences Clinical Los Angeles Inc.](https://www.keypedia.com/companies/altasciences-clinical-los-angeles-inc/977107a9-0682-40d1-b775-8c0cb8c7e822)
- [Bausch Health Americas, Inc.](https://www.keypedia.com/companies/bausch-health-americas-inc/46368cf4-fd1b-4ed0-a010-ae5ccd022cb6)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/lauren-iaconoconnors/0695b59c-bcae-4943-b1b7-183d27167d38)
- [Joan H Mulinde](https://www.keypedia.com/people/joan-h-mulinde/2e55836b-795f-411a-8812-8ba596ea5229)
